Ether (ETH) options currently exhibit a wider put-minus-call implied-volatility spread than Bitcoin (BTC) options, indicating a stronger relative premium for put-side protection in Ether. As of October 19, the spread for Ether options expiring October 21 was 8.24 percentage points, down from 11.27 points a day earlier, while Bitcoin's spread was 2.67 points, also narrowing from 6.18 points. This suggests that investors are paying more for downside protection in Ether compared to Bitcoin, reflecting differing market sentiment. Bitcoin's price fluctuated around $80,000 to $82,000 during Asian trading, while Bitcoin and altcoins showed recent price declines, with Bitcoin down about 1.8% and altcoins about 4.0% over the past week.
Ether options volatility skew is the subject, with Pluang market data provided as context. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 19, 2026 23:31 WIB: Among 50 major cryptocurrencies priced on Pluang, 41 rose and 8 fell today. Notable movers include ATOM at Rp32.037 (+7.50%, 23% Sell / 77% Buy, typical hold 61 days), UNI at Rp132.257 (+5.75%, 86% Sell / 14% Buy, typical hold 65 days), and EGLD at Rp64.958 (+4.25%, 81% Sell / 19% Buy, typical hold 86 days). The most notable figure is ATOM's 7.50% daily price increase.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
